Auvi-q Injection, Solution
Product Images NDC 71872-7333

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Auvi-q (NDC 71872-7333). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7333.pdp (7333)

7333.pdp (7333)
Auvi-Q epinephrine injection, USP 0.15 mg prefilled auto-injector label. The label indicates it is for single-use intramuscular administration for allergic emergencies in patients weighing 33 to 66 pounds. It contains 0.15 mg of epinephrine per 0.15 mL with sodium chloride and sodium bisulfite, and water for injection. Manufactured by kaleo, Inc. in Richmond, VA, origin Germany, repackaged and distributed by Medical Purchasing Solutions, Scottsdale, AZ.*
FDA Label Image

Auvi.pdp (Auvi)

Auvi.pdp (Auvi)
The label for Auvi-Q 0.15 mg epinephrine injection, USP auto-injector is shown. It is a blue rectangular label with instructions to pull the device up from its case. It states the product is for allergic emergencies in patients weighing 33 to 66 pounds. Storage instructions indicate to keep at room temperature and avoid freezing. Manufactured for kaléo, Inc. with website www.auvi-q.com.*
FDA Label Image

Chemical Structure (Auvi Q 01)

Chemical Structure (Auvi Q 01)
Chemical structure diagram of epinephrine showing its phenolic benzene ring with hydroxyl groups, and side chains including an amine group.*
FDA Label Image

Figure A (Auvi Q 02)

Figure A (Auvi Q 02)
Illustration showing the Auvi-Q injection device and its outer case. The device features a speaker, LED lights, viewing window, red safety guard on the needle end, and a black base. The outer case has a white body with blue top tabs and a green upward arrow on the front.*
FDA Label Image

Figure B (Auvi Q 03)

Figure B (Auvi Q 03)
An instructional illustration showing a pair of hands holding an Auvi-Q epinephrine injection device. The hands demonstrate how to slide the device cover in an up and down motion to open or close it, indicated by arrows around the device.*
FDA Label Image

Figure C (Auvi Q 04)

Figure C (Auvi Q 04)
An instructional illustration showing a hand holding an Auvi-Q autoinjector device positioned over a person's thigh. Two downward black arrows indicate the injection direction into the thigh muscle. The image demonstrates the correct orientation for intramuscular injection using the Auvi-Q epinephrine autoinjector.*
FDA Label Image

Figure D (Auvi Q 05)

Figure D (Auvi Q 05)
An instructional illustration depicting a person holding an Auvi-Q epinephrine injection device against their thigh for intramuscular administration, accompanied by a stopwatch highlighting the instruction to hold the device for 2 seconds during use.*
FDA Label Image

Figure E (Auvi Q 06)

Figure E (Auvi Q 06)
An instructional illustration showing a person holding an Auvi-Q epinephrine injection device against their outer thigh, highlighting the proper placement for intramuscular injection. Next to it is a stopwatch depiction indicating a 2-second countdown, emphasizing the recommended injection duration.*
FDA Label Image

Figure A1 (Auvi Q 07)

Figure A1 (Auvi Q 07)
An illustrated diagram of the Auvi-Q trainer device and outer case. The device labeled as a trainer for Auvi-Q epinephrine injection includes labeled parts such as Speaker, Housing, LEDs, Base, and Safety Guard. The outer case shows instructions to pull up the trainer for practice use only, highlighting it is reusable and indicating where to find complete instructions.*
FDA Label Image

Figure A2 (Auvi Q 08)

Figure A2 (Auvi Q 08)
Auvi-Q Trainer kit packaging for epinephrine injection, labeled as a trainer device and not for actual drug administration. The package is white and black with the word TRAINER prominently displayed in large letters, indicating its use for practice rather than actual epinephrine administration.*
FDA Label Image

Figure A3 (Auvi Q 09)

Figure A3 (Auvi Q 09)
Auvi-Q 0.15 mg epinephrine injection solution in a red and navy blue autoinjector device with clear dosing instructions and dosage strength labeled on the front. The labeler is Medical Purchasing Solutions, LLC. The device is designed for intramuscular injection and is marked for human prescription use.*
FDA Label Image

Figure A4 (Auvi Q 10)

Figure A4 (Auvi Q 10)
Auvi-Q 0.15 mg epinephrine injection, solution in a prefilled autoinjector device. The packaging includes storage and usage instructions with a pull tab to activate the device. Labeler is Medical Purchasing Solutions, LLC, with a blue and white color scheme and clear illustrations for usage steps.*
FDA Label Image

Figure A5 (Auvi Q 11)

Figure A5 (Auvi Q 11)
Auvi-Q 0.15 mg epinephrine injection solution intramuscular auto-injector packaging label. The front label displays the brand name, generic name, strength, dosage form, and labeler (Medical Purchasing Solutions, LLC). The back label includes detailed step-by-step graphical instructions for use, emphasizing pulling the device away from the thigh after injection.*
FDA Label Image

Figure B (Auvi Q 12)

Figure B (Auvi Q 12)
An instructional illustration showing a hand holding an Auvi-Q autoinjector device. The image depicts upward and downward arrows indicating motion, with a large arrow on the device's central section suggesting to slide or push the component as part of the usage procedure.*
FDA Label Image

Figure C (Auvi Q 13)

Figure C (Auvi Q 13)
An instructional diagram showing a hand holding the Auvi-Q epinephrine auto-injector with the device tip pressed against a finger. Arrows indicate the proper pressing action needed to administer the injection intramuscularly using the device.*
FDA Label Image

Figure D (Auvi Q 14)

Figure D (Auvi Q 14)
Illustration showing a hand holding an Auvi-Q epinephrine injection device at the thigh, demonstrating injection technique by pressing it against the leg. Adjacent image shows a stopwatch indicating a 2-second count, highlighting the recommended injection duration.*
FDA Label Image

Figure E (Auvi Q 15)

Figure E (Auvi Q 15)
An instructional illustration showing a person pressing the Auvi-Q epinephrine injection device against the outer thigh, accompanied by a stopwatch image indicating a 2-second count for administration. The depiction highlights the proper injection technique and timing for the intramuscular epinephrine solution.*
FDA Label Image

Figure F (Auvi Q 16)

Figure F (Auvi Q 16)
An instructional illustration showing a hand holding an Auvi-Q epinephrine injection device. The image demonstrates the proper method of not holding the black base while inserting the red safety guard, with arrows indicating the insertion direction.*
FDA Label Image

Figure G (Auvi Q 17)

Figure G (Auvi Q 17)
An instructional illustration showing a hand holding an Auvi-Q epinephrine injection device, demonstrating how to remove the outer case by pressing and sliding as indicated by arrows. The device is for intramuscular injection and labeled with the Auvi-Q brand name.*
FDA Label Image

0.15 mg Device Label (Auvi Q 23)

0.15 mg Device Label (Auvi Q 23)
Label of Auvi-Q 0.15 mg epinephrine injection, USP auto-injector for allergic emergencies. The label instructs users to pull the red safety guard and place the black end against the outer thigh, pushing firmly for 2 seconds. Manufactured by kaleo, Inc. in Richmond, VA, the label advises seeking medical attention after use and disposal instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.